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ABSTRACT:  35 
Wall shear rate (WSR) is an important stimulus for the brachial artery flow-mediated 36 
dilation (FMD) response. However, WSR estimation near the arterial wall by conventional 37 
Doppler is inherently difficult. To overcome this limitation, we utilised multi-gate Doppler to 38 
accurately determine the WSR stimulus near the vessel wall simultaneously with the FMD 39 
response using an integrated FMD system [Ultrasound Advanced Open Platform (ULA-OP)]. 40 
Using the system, we aimed to perform a detailed analysis of WSR-FMD response and 41 
establish novel WSR parameters in a healthy young population. Data from 33 young healthy 42 
individuals (27.5±4.9yrs, 19F) were analysed. FMD was assessed with reactive hyperemia 43 
using ULA-OP. All acquired raw data were post-processed using custom-designed software 44 
to obtain WSR and diameter parameters. The acquired velocity data revealed that non-45 
parabolic flow-profiles within the cardiac cycle and under different flow-states, with 46 
heterogeneity between participants. We also identified seven WSR magnitude and four WSR 47 
time-course parameters.  Among them, WSR area under the curve until its return to 48 
baseline was the strongest predictor of the absolute (R2=0.25) and percentage (R2=0.31) 49 
diameter changes in response to reactive hyperemia. For the first time, we identified mono- 50 
and biphasic WSR stimulus patterns within our cohort that produced different magnitudes 51 
of FMD response [absolute diameter change: 0.24±0.10mm (monophasic) vs 0.17±0.09mm 52 
(biphasic), p<0.05]. We concluded that accurate and detailed measurement of the WSR 53 
stimulus is important to comprehensively understand the FMD response and that this 54 
advance in current FMD technology could be important to better understand vascular 55 
physiology and pathology.  56 
 57 
 58 
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 61 
New & Noteworthy 62 
An estimation of wall shear rate (WSR) near the arterial wall by conventional Doppler 63 
ultrasound is inherently difficult. Using a recently-developed integrated FMD ultrasound 64 
system, we were able to accurately estimate WSR near the wall, and identified a number of 65 
novel WSR variables that may prove to be useful in the measurement of endothelial 66 
function, an important biomarker of vascular physiology and disease.   67 
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INTRODUCTION:  68 
Brachial artery flow mediated dilation (FMD) has been used extensively to assess the 69 
function and health of the vascular endothelium since its first use by Celermajer et al (5). 70 
However, a persistent problem with this method is the inability to accurately measure the 71 
wall shear stress stimulus that produces the measured FMD response. This is a perplexing 72 
problem that has resulted in the extensive use of Doppler ultrasound peak velocity to 73 
estimate wall shear stress, or its surrogate, wall shear rate (WSR). This is currently the only 74 
practical solution available when measuring FMD, but this method underestimates WSR (22) 75 
and is a blunt instrument to dissect the complex and dynamic WSR events occurring during 76 
FMD. 77 
 78 
In the absence of WSR data, the accurate interpretation of the FMD response may be 79 
confounded and this has likely limited its full potential as a scientific and clinical tool. For 80 
example, the mechanisms of diminished FMD could involve impaired brachial artery 81 
endothelial function or alternatively could result from altered microvascular function 82 
blunting the hyperaemic response and, in turn, WSR stimulus. Knowledge of the WSR 83 
stimulus may also help to resolve and exploit issues relating to differences in baseline 84 
diameter and ‘low-flow’ vasoconstriction occurring during cuff-occlusion (2, 11, 26), 85 
providing a more comprehensive characterization of the underlying vascular physiology. 86 
 87 
For physiological studies, the optimal tool for FMD needs to combine continuous and 88 
simultaneous measurement of WSR and vessel diameter in order to comprehensively 89 
characterise the WSR-FMD stimulus-response relationship. We have previously reported a 90 
method to simultaneously measure WSR and vessel diameter during FMD (28). Unlike the 91 
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estimation of WSR from Doppler ultrasound, this system uses multi-gate spectral Doppler to 92 
acquire velocity data at different sites across the vessel diameter and close to the vessel 93 
wall, producing a continuous velocity profile from near to far wall (27). These data can be 94 
used to generate a detailed spectral Doppler profile across the vessel diameter and close to 95 
the vessel wall to accurately determine WSR (27). This overcomes the limitation of a single 96 
pulsed-wave Doppler sample-gate and the need to assume a perfect parabolic velocity 97 
profile (12).  98 
 99 
Using this method we were able to show that estimation of WSR by conventional Doppler 100 
ultrasound is inaccurate (28), at least partly because the presumed parabolic velocity profile 101 
(15) is often asymmetric during hyperaemia and varies considerably through the cardiac 102 
cycle (12, 23, 28). Because of this, the extant literature presents a well characterised arterial 103 
diameter response to reactive hyperaemia, but lacks a well characterised WSR stimulus.  104 
 105 
We have recently enhanced and refined this system in a collaborative effort between 106 
engineers, clinicians and physiologists with extensive experience of using ultrasound, to 107 
provide a sophisticated tool that can advance current FMD technology. This novel tool has 108 
an additional acquisition system capable of storing the large amount of raw data generated 109 
during the FMD procedure (18, 19). This has vastly expanded data collection capacity so that 110 
it can continuously measure WSR and vessel diameter over an extended period of time to 111 
provide accurate, detailed and simultaneous WSR-FMD stimulus-response data. 112 
 113 
Here we report, for the first time, the use of this method. Our overall aim was to establish a 114 
new benchmark in WSR-FMD measurement. First, we wanted to establish the relevant 115 
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variables derived from the measurement system. Second, because the WSR-FMD response 116 
in humans is currently unknown, we wanted to establish a ‘normal reference’ by conducting 117 
a detailed analysis of the WSR-FMD response in a cohort of healthy young adults. Third, we 118 
wanted to determine which WSR variables were the best predictors of a normal FMD 119 
response. Fourth, we wanted to investigate the patterns of WSR during hyperaemia and 120 
determine whether these influenced the FMD response. We had noticed two distinct WSR 121 
patterns during our pilot work: A ‘monophasic’ pattern, where WSR increases sharply 122 
reaching its peak in one go during hyperaemia; and a ‘biphasic’ pattern, where WSR 123 
increases sharply followed by a slow increase before reaching its peak during hyperaemia. 124 
These two distinct WSR patterns cannot readily be seen with conventional Doppler and we 125 
wanted to know if the biphasic WSR pattern resulted in a greater magnitude of hyperaemic 126 
WSR than the monophasic WSR pattern, and if so, whether this greater WSR produced a 127 
greater brachial artery vasodilatory response than the monophasic WSR pattern. 128 
 129 
METHODS: 130 
Participants 131 
Thirty-three young individuals (27.5±4.9 yrs, 19 females) participated in this study. Of these, 132 
15 participants were studied in Exeter, UK and 18 in Pisa, Italy. All were healthy, without 133 
hypertension, type 2 diabetes, dyslipidaemia, or overt cardiovascular disease. UK National 134 
Research Ethics Service South West Committee and the institutional ethics committee at 135 
University of Pisa approved all study procedures and written informed consent was 136 
obtained from all participants.  137 
 138 
Experimental procedures 139 
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Participants arrived in our temperature-controlled laboratories after an overnight fast, had 140 
blood samples drawn for biochemical analysis, consumed a standardized meal and rested 141 
for 20 min before initiation of the study protocol.  142 
 143 
Brachial artery FMD was assessed non-invasively following established guidelines (6, 10, 24) 144 
and as previously described by us elsewhere (2, 8, 9). Briefly, participants lay supine on an 145 
examination bed with the right arm fixed in position and immobilised using a positioning 146 
pillow on a metal table. A small blood pressure cuff was placed around the proximal part of 147 
the forearm. A complete and open research system for ultrasound imaging and acquisition, 148 
the Ultrasound Advanced Open Platform (ULA-OP; Microelectronics Systems Design 149 
Laboratory, University of Florence, Italy) was connected to a high-frequency linear array 150 
transducer LA523 (Esaote SpA, Florence, Italy) and used to obtain both B-mode and multi-151 
gate velocity data from the brachial artery (4). Once the optimal ultrasound image was 152 
obtained, the transducer was carefully clamped to prevent movement during the procedure 153 
using a custom-designed transducer holder. If necessary, a micro-adjuster was used to 154 
obtain a precisely aligned image. 155 
 156 
Baseline brachial artery image and blood velocity were recorded for 60 s. Reactive 157 
hyperemia was then induced by rapidly inflating the forearm cuff (AI6, Hokanson, Bellevue, 158 
WA) to 250 mmHg to occlude forearm blood flow for 5 min. At 5 min, the cuff was rapidly 159 
deflated. Recording was restarted 30 s before deflation and continued until 5 min following 160 
deflation. 161 
 162 
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In a sub-set of participants (n=13), baseline brachial artery diameter measurements were 163 
repeated after a 15 min rest period, and endothelium-independent dilation was assessed 164 
using sub-lingual nitroglycerin spray (0.4 mg). A 60 s recording was started 9 min after 165 
administering the spray. We have previously found that measurement between 9 and 10 166 
minutes after nitroglycerin administration captures maximal endothelial-independent 167 
vasodilation (unpublished observation). 168 
 169 
Integrated FMD evaluation system 170 
An integrated system capable of estimating both stimulus (WSR) and response (diameter) 171 
during the FMD assessment was developed by suitably modifying the existing hardware and 172 
software of the ULA-OP as well as by developing a post-processing software platform (19, 173 
28). In particular, the ULA-OP offers much wider experimental possibilities than 174 
commercially-available Doppler ultrasound systems as it can be re-configured at run time 175 
and enables complete access to imaging data in every stage of the processing chain. The 176 
ULA-OP system also provides real-time imaging visualization functions in connection to a 177 
host personal computer. For the FMD data acquisition, an additional dedicated acquisition 178 
board was developed to store all raw (quadrature demodulated) echo data over a long time 179 
interval (up to 15 min). Furthermore, the ULA-OP system was recently upgraded to include 180 
the real-time measurement of arterial diameter (19).    181 
 182 
In addition, a post-processing software platform was developed in order to evaluate 183 
endothelial function (19). It is based on Matlab® (The Mathwork Inc, Natick, MA) and 184 
consists of several processing blocks that, starting from the baseband acquired data, 185 
compute B-mode images and multi-gate spectral Doppler profiles. B-mode processing 186 
9 
 
                                                                                                                                                                          
organizes the data in lines and frames, interpolates them, applies 2D spatial filters, and 187 
finally applies a logarithmic scale compression. Multi-gate spectral Doppler processing 188 
reconstructs the information about the distribution of blood velocities at different depths 189 
(256 up to 512 gates) through 256-point fast Fourier transforms (FFTs), hence the profiles 190 
are low-pass filtered in order to remove the low-frequency spectral components through a 191 
frequency domain mask.  In cascade to the latter blocks, other specific processing blocks 192 
extract wall positions of the artery and its diameter  through a first order absolute central 193 
moment (FOAM) algorithm (7), as well as WSR by a method that employs the direct 194 
measurement of the whole velocity profile (20). Next, diameter and WSR time trends are 195 
saved in output files which are finally loaded by a further Matlab® interface that extracts the 196 
main parameters needed to investigate endothelial function.   197 
 198 
Measurements of wall shear rate and diameter 199 
The signal elaboration system extracts detailed WSR parameters for describing both 200 
magnitude and time-course of WSR changes. Seven WSR magnitude parameters were 201 
analysed: 1) WSR at baseline, 2) WSR during low-flow, 3) WSR at peak hyperemia, 4) 202 
absolute WSR increase from baseline, 5) percentage WSR increase from baseline, 6) area 203 
under the WSR curve until time to peak dilation (WSR aucttp), and 7) area under the WSR 204 
curve (WSR auc), measured between cuff release and the point at which WSR returned to 205 
the baseline value. Four WSR time-course parameters were analysed: 1) first slope of WSR 206 
increase during hyperemia (WSR SL1, an initial steep increase), 2) the second slope of WSR 207 
increase during hyperemia (WSR SL2, a gradual increase after the initial steep increase; the 208 
biphasic pattern only), 3) time to peak WSR (WSR Tp), and 4) time to return to baseline WSR 209 
(WSR Tb). The monophasic and biphasic patterns of WSR increase were defined as: 1) 210 
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Monophasic - the peak WSR value was reached with a single, continuous steep increase 211 
only; 2) Biphasic - the peak WSR value was reached with an initial steep increase followed by 212 
a gradual second increase.  213 
 214 
The signal elaboration system also extracts detailed diameter parameters. Three diameter 215 
magnitude parameters were analysed: 1) baseline diameter, 2) absolute diameter increase 216 
from baseline, and 3) percentage diameter increase from baseline. Two diameter time-217 
course parameters were analysed: 1) time to peak diameter, and 2) time to return to 218 
baseline diameter, taken as the point at which diameter returns to its baseline values or 219 
plateaus.   220 
 221 
Statistical analysis 222 
Data are presented as means±SD for variables with a normal distribution, and median 223 
(interquartile range) for variables with a skewed distribution. A partial correlation analysis 224 
was performed between WSR parameters and diameter changes (absolute and percentage) 225 
controlling for the study centre in the whole cohort. A stepwise multivariate regression 226 
analysis was also performed in the whole cohort to determine the strongest predictor(s) of 227 
WSR parameters that were significantly associated with both absolute and percentage 228 
diameter changes in the partial correlation analysis (WSR at peak hyperaemia, WSR auc and 229 
absolute WSR increase from baseline). The study centre was also included as an 230 
independent variable in the model.  Analysis of covariance (study centre as a covariate) was 231 
used to examine the differences in variables between monophasic and biphasic groups. A 232 
log-transformation was used for variables with skewed distribution before statistical 233 
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analysis. All statistical analysis was conducted using IBM SPSS Statistics 22 (IBM, Armonk, 234 
NY). Significance was set at p<0.05.   235 
 236 
RESULTS: 237 
Selected baseline characteristics of the study participants are shown in Table 1. Body mass 238 
index (24.1±3.0 vs 21.7±2.7 kg/m2) and systolic blood pressure (121.5±7.5 vs 108.6±8.8 239 
mmHg) were higher in male participants than female participants (both p<0.05). Other 240 
participants’ characteristics were similar between males and females.     241 
 242 
Establishment of relevant WSR variables and their ‘normal reference’ values 243 
Figure 1 exhibits examples of multi-gate Doppler spectral profiles obtained at different time 244 
points in the cardiac cycle at baseline and peak hyperemia, to illustrate the variability and 245 
complexity of the WSR events occurring during FMD. A schematic description of detailed 246 
WSR parameters extracted from the integrated FMD system is also presented in Figure 2. In 247 
addition, parameters of WSR and diameter during brachial artery FMD and nitroglycerin-248 
mediated dilation in a healthy young cohort are shown in Table 2.   249 
 250 
WSR variables that best predict a normal FMD response  251 
The results of partial correlation analysis between WSR parameters and diameter changes 252 
during brachial artery FMD in the whole cohort are shown in Table 3. WSR at peak 253 
hyperemia, WSR auc and absolute WSR increase were significantly associated with both 254 
absolute and percentage diameter changes (all p<0.05). WSR SL1 and WSR aucttp were 255 
significantly associated with percentage diameter changes (both p<0.05). We then 256 
performed a stepwise multivariate regression analysis to determine the strongest WSR 257 
12 
 
                                                                                                                                                                          
predictor(s) of diameter changes during brachial artery FMD in the whole cohort. When 258 
WSR at peak hyperemia, WSR auc, absolute WSR increase and the study centre were all 259 
included in the same model at the same time, WSR auc was the best predictor of absolute 260 
brachial artery diameter change (β=0.503, R2=0.25) and percentage diameter change 261 
(β=0.560, R2=0.31). Collinearity statistics (tolerance and variance inflation factor) did not 262 
indicate a collinearity problem in this model. These associations remained significant when 263 
including WSR at baseline or baseline brachial artery diameter in the model above. 264 
 265 
Influence of the WSR patterns during hyperemia on the FMD response 266 
A schematic description of the monophasic and biphasic patterns of WSR increase is 267 
presented in Figure 3. Table 4 shows the parameters of WSR and diameter during brachial 268 
artery FMD and nitroglycerin-mediated dilation stratified by monophasic and biphasic WSR 269 
increase patterns. During reactive hyperemia, we observed the monophasic pattern of WSR 270 
increase in 15 participants (9 females) and the biphasic pattern of WSR increase in 18 271 
participants (10 females). Individuals with the biphasic pattern showed a significantly 272 
greater WSR SL1 than those with the monophasic pattern (p<0.05). The parameters that 273 
were associated with diameter changes (WSR at peak hyperemia, WSR auc and absolute 274 
WSR increase from baseline) were significantly greater in the biphasic pattern than the 275 
monophasic pattern (Figure 4A-C). Similarly, individuals with the biphasic pattern showed a 276 
significantly greater WSR baseline and WSR aucttp than those with the monophasic pattern 277 
(all p<0.05). WSR Tp took longer in individuals with the biphasic pattern than in those with 278 
the monophasic pattern (p<0.05). The absolute diameter increase following reactive 279 
hyperemia was significantly greater in individuals with the biphasic pattern than in 280 
individuals with the monophasic pattern (0.24±0.10 mm vs 0.17±0.09 mm, p<0.05, Figure 281 
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5A). Percentage diameter increase tended to be greater in individuals with the biphasic 282 
pattern than individuals with the monophasic pattern (7.6±3.3 % vs 5.3±3.5 %, p=0.08, 283 
Figure 5B). However, to determine if WSR auc stimulus (the strongest predictor of FMD) 284 
explained the difference in FMD response between the two groups, we used an ANCOVA 285 
model that included WSR auc. This analysis showed that there were no differences in 286 
absolute or percentage brachial artery diameter change during FMD between the 287 
monophasic and biphasic groups when the WSR auc stimulus was taken into account (data 288 
not shown). Following nitroglycerin spray, there were no differences in WSR or change in 289 
brachial artery diameter between the mono- and biphasic groups (Table 4). 290 
 291 
DISCUSSION: 292 
Our main findings are that, using multi-gate spectral Doppler, we were able to acquire and 293 
extract seven WSR magnitude and four WSR time-course parameters over a long time-294 
period to more comprehensively characterize the FMD response. We were also able to 295 
derive the first WSR-FMD stimulus-response data in humans using this method to provide a 296 
first point of reference in healthy, young adults. Furthermore, we were able to show that in 297 
this cohort, the WSR area under the curve until its return to baseline was the strongest 298 
predictor of the brachial artery diameter change in response to hyperemia. For the first 299 
time, we were able to identify mono- and biphasic WSR stimulus patterns within our cohort 300 
that produced different magnitude of FMD response. However, these responses were not 301 
different when the strongest WSR predictor (WSR auc) was statistically taken into account, 302 
illustrating the importance of knowing the WSR stimulus in order to correctly interpret the 303 
response. 304 
 305 
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Novel WSR variables, observations and comments on their values 306 
We identified seven WSR magnitude variables and four WSR time-course variables that add 307 
novel measurements to the WSR-FMD response. These measurements took into account 308 
key phases of the FMD procedure and in combination with more traditional measurements, 309 
provide a comprehensive characterization of FMD-WSR response. Our data show that WSR 310 
is reduced during cuff-occlusion to about one-third that of baseline and that during reactive 311 
hyperaemia, peak WSR is almost six-times greater compared with baseline and is over 18-312 
times greater compared with WSR during cuff-occlusion. 313 
 314 
Our data also show that peak WSR was reached quickly (~12s) and preceded the time of 315 
peak dilation by an average of ~43s. We also note that the time taken to reach peak WSR 316 
was relatively homogenous between subjects, whereas there was considerable inter-317 
individual variability in the time for diameter to reach peak diameter. The time taken for 318 
WSR to return to baseline (~104s) preceded the time for diameter to return to baseline in 15 319 
participants but in the remaining 18, arterial diameter returned to baseline before WSR. The 320 
physiological mechanisms underlying this variability are unknown and were beyond the 321 
scope of this study, but putatively provide an opportunity to better understand the arterial 322 
response to the dynamic WSR changes during reactive hyperemia. 323 
 324 
Multi-gate Doppler WSR auc is a good predictor of FMD 325 
A key aim of the current study was to determine which WSR stimulus variable was the best 326 
predictor of the FMD response in healthy young adults. In a regression model that included 327 
the three WSR variables that were significantly associated with both absolute and relative 328 
diameter change (WSR peak, WSR auc and WSR absolute increase), we found that WSR auc 329 
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was the only predictor of both absolute (R2=0.25) and relative (R2=0.31) diameter changes, 330 
and this was the case irrespective of whether baseline diameter was included in the model.  331 
Given that WSR auc explains 25-31% of the variance in the regression model, it seems 332 
reasonable to conclude that this is an important predictor of the FMD response, whilst 333 
acknowledging the limitations of the R2 statistics. Other factors influencing diameter change 334 
likely include the stiffness of the brachial artery, mechano-transduction of WSR to the 335 
endothelium, cell signalling in response to the transduced stimulus and the regulation of 336 
smooth muscle cell tone. 337 
 338 
The association between WSR and the brachial artery FMD response has previously been 339 
reported in a cohort of young adults (14, 16, 17, 25). Using a similar cross-sectional study 340 
design as ours, Thijssen and colleagues found that WSR aucttp explained 14% of the 341 
variance in the FMD response in young healthy adults (25) and we found that WSR auc using 342 
our method explained 25-31% of the variance in the FMD response. This suggests that the 343 
WSR stimulus is an important contributor to the FMD response, but whether FMD should be 344 
‘normalized’ to WSR is a contentious issue. Whereas some have suggested ‘correcting (or 345 
normalizing)’ data by dividing FMD by WSR (17), recent guidelines (24) recommend 346 
reporting WSR and FMD together without corrections. Consistent with this, where WSR has 347 
been measured with multi-gate Doppler, we suggest that the ‘normal’ stimulus-response 348 
characteristics should be reported as WSR auc and FMD together, and that the association 349 
between WSR auc and FMD are determined using statistical models. It was not the purpose 350 
of this study to determine this relationship in characteristically different populations or 351 
diseased populations; instead, the data presented here, together with the novel method of 352 
data acquisition, provide a platform for future studies of this nature.  353 
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 354 
Mono- and biphasic WSR responses in healthy young adults 355 
An advantage of being able to continuously measure WSR was that we were able to 356 
observe, for the first time to our knowledge, two distinct patterns of WSR increase during 357 
reactive hyperemia: A ‘monophasic’ and a ‘biphasic’ WSR pattern that occurred between 358 
cuff release and peak WSR. Compared to the monophasic pattern, the biphasic pattern was 359 
associated with a greater magnitude as well as faster kinetics (steeper increase) of WSR 360 
increase during hyperemia. The biphasic pattern was also associated with a greater brachial 361 
artery vasodilatory response. However, when WSR auc stimulus was statistically taken into 362 
account, the vasodilatory response was no longer different between mono- and biphasic 363 
groups; that is, the dilation was matched to the WSR stimulus. This finding shows that 364 
within an otherwise characteristically similar cohort, there are two distinct vasodilatory 365 
responses to reactive hyperemia but that vasodilation is, ultimately, matched to the WSR 366 
stimulus.  367 
 368 
The two different WSR responses may allude to underlying physiological differences 369 
between the cohorts, although their significance is unknown. It is possible that different 370 
mechanisms regulating blood flow during hyperemia produce the two different stimulus-371 
response relationships. There are two candidate sites for the regulation of FMD: First, the 372 
arterial endothelium above the cuff that is experiencing an increase in WSR during 373 
hyperemia; second, the downstream microvasculature below the cuff that has dilated 374 
during cuff-occlusion and experiences a sudden increase in blood flow. During hyperemia, 375 
the endothelium of the brachial artery stimulates dilation in order to normalise the 376 
increased WSR brought about by hyperaemic flow. Differences in mechano-transduction of 377 
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WSR or differences in the paracrine response to the change in WSR could cause differences 378 
in the temporal pattern of WSR and magnitude of dilation. Microvascular function 379 
downstream of the cuff-occlusion site could also explain different WSR patterns (3, 13) 380 
because flow during reperfusion is influenced by downstream microvascular dilation (6). 381 
Microvessels also respond to reperfusion, including a vasoconstrictor response that likely 382 
influences upstream blood flow and, therefore, WSR. Consistent with this, we have 383 
previously shown distinct differences in the autoregulatory response to reperfusion by 384 
microvessels that temporally altered perfusion and oxygenation of tissue (1). Structural 385 
alterations in the microcirculation (21) can also influence its ability to respond to ischemia-386 
reperfusion, which might influence the upstream WSR stimulus and explain differences 387 
between individuals. This is a first observation of two distinct WSR increase patterns and we 388 
did not explore control mechanisms in the first instance. Nor do we know if these WSR 389 
increase patterns are observed in characteristically different populations or diseased 390 
populations. Future studies will shed light on these issues and will ultimately determine 391 
whether there is value in determining two different WSR responses during the FMD 392 
assessment. But the ability to measure different hyperemic responses itself may be useful 393 
for future physiological studies. 394 
 395 
The flow velocity profile is not always parabolic and symmetrical 396 
One advantage of using multi-gate Doppler is that the flow velocity profile (normally 397 
assumed to be parabolic and symmetric, but which cannot be seen with conventional 398 
Doppler) can be seen in real time during data acquisition. One revelation from the current 399 
study was the heterogeneity in this flow-profile within the cardiac cycle, under different 400 
flow-states, and between subjects. During hyperemia, the shape of the parabola was seen 401 
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to be blunt, M-shaped, asymmetric and symmetric (see examples in Figure 1) and the shape 402 
of the parabola typically varied within the same cardiac cycle. Heterogeneity was also 403 
observed between subjects and was apparent at baseline, low-flow and during reactive 404 
hyperemia. These observations point to the importance of being able to detect flow velocity 405 
at different spatial points in the vessel in order to accurately measure WSR by extracting 406 
these local velocities. 407 
 408 
‘Low-flow’ WSR and diameter during cuff-occlusion 409 
We also found that all participants reduced WSR during cuff-occlusion but only 17 exhibited 410 
reduced brachial artery diameter (1 remained similar to baseline and 15 exhibited increased 411 
brachial artery diameter). This finding suggests that the brachial artery response to low-flow 412 
might be independent of WSR, at least in young, healthy adults.  413 
 414 
Reduced vessel diameter immediately after cuff-release and its influence on WSR increase 415 
and diameter response 416 
We noticed that immediately after cuff-release, 24 participants showed a reduced brachial 417 
artery diameter and nine did not. To determine whether this reduction of diameter 418 
immediately after cuff-release influenced the initial increase in WSR as well as the 419 
subsequent FMD response, we performed a sub-group analysis of participants stratified by 420 
the presence or absence of reduced brachial diameter. We found that absolute WSR 421 
increase (496.1±128.4 vs 477.6±134.4 1/s, p=0.733) and WSR SL1 (80.3±24.5 vs 78.7±25.5 422 
1/s2, p=0.874) were both similar between those with reduced brachial diameter and those 423 
without. Similarly, absolute diameter change (0.20±0.10 vs 0.22±0.12 mm, p=0.707) and 424 
relative diameter change (6.5±3.9 vs 6.8±3.9 %, p=0.852) were not different between those 425 
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with reduced diameter and those without. These observations indicate that the reduced 426 
brachial artery diameter immediately after cuff-release does not play a major role in the 427 
initial increase in WSR as well as the subsequent FMD response, at least in our population of 428 
young, healthy adults. The reduction in diameter may be due to an acute pressure drop, a 429 
brief period of turbulent flow, and alteration of smooth muscle cell tone or some 430 
combination. 431 
 432 
WSR response during nitroglycerin-mediated vasodilation 433 
There is a paucity of WSR data during the assessment of nitroglycerin-mediated 434 
vasodilation. It has been used as an endothelium-independent control test to ensure the 435 
validity of the FMD assessment. The application of nitroglycerin, thought to be an 436 
exogenous nitric oxide donor, reduces smooth muscle cell tone and induces vasodilation. As 437 
such, this has been considered WSR-independent and, thus, that there is no clear benefit for 438 
acquiring WSR data during the assessment. Our observations support the position that 439 
nitroglycerin-mediated vasodilation is WSR-independent, because WSR was slightly reduced 440 
(Table 2) at the time that peak diameter occurred following administration of nitroglycerin. 441 
Reduced WSR is likely a result of increased brachial artery diameter at the time of 442 
measurement and suggests that nitroglycerin administration over-rides any effect of altered 443 
WSR.  444 
 445 
Implications from this study 446 
Our study highlights the importance of being able to measure the WSR stimulus as well as 447 
the vasodilatory response to hyperemia. An accurate estimation of WSR close to the arterial 448 
wall by conventional Doppler ultrasound, especially during reactive hyperemia, is inherently 449 
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difficult, further exacerbated by the uncertainties associated with the assumptions used to 450 
estimate WSR (especially that blood flow maintains a parabolic profile). We have shown that 451 
multi-gate Doppler overcomes these limitations by measuring blood flow velocity from 452 
near-to-far wall and by directly estimating WSR close to the arterial wall. By integrating 453 
these measurements with continuous and simultaneous measurement of arterial diameter, 454 
we were able to generate detailed information about the WSR stimulus and FMD response 455 
that has not been seen previously.  For example, the system enabled us to reveal the 456 
monophasic and biphasic WSR patterns and allowed us to determine the most important 457 
WSR predictor of FMD. We are also able to characterise the ‘normal WSR-FMD relationship 458 
in our cohort of healthy young adults, establishing a reference for these measurements. As 459 
such, we have demonstrated the usefulness of multi-gate Doppler as a modality for 460 
measuring arterial WSR, in this instance integrated into the ULA-OP system.  461 
 462 
Overall, our study represents a technical advance that enables comprehensive WSR-FMD 463 
stimulus-response measurement within an integrated ultrasound system. The need to 464 
measure WSR continues to cause researchers to rely heavily on imprecise WSR data derived 465 
from vessel center-line peak velocity, creating uncertainties for the accurate interpretation 466 
of the FMD response. In a clinical setting, measurement of WSR has found little utility. Our 467 
broader aim is to provide a better tool for researchers and clinicians to augment the 468 
accuracy and usefulness of WSR-FMD measurement. This has the potential to expand 469 
current understanding of vascular physiology and pathophysiology, vascular ageing and the 470 
vascular response to interventions. In a clinical setting, this has the potential to improve 471 
clinical evaluation and management of patients with many diseases that involve blood 472 
vessels.  473 
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 474 
Limitations     475 
We did not assess brachial artery stiffness which has been reported to affect the magnitude 476 
of FMD response (29) and may have contributed to the differences seen here. In addition, 477 
due to the cross-sectional nature of this study, we cannot infer any causation from our 478 
results. Finally, because multi-gate spectral Doppler is an extension of pulsed-wave (PW) 479 
Doppler, it has the same limitations of PW Doppler; for example, analysis limited to the axial 480 
velocity component (28) or possible velocity detection difficulties in the presence of high-481 
level clutter.  482 
 483 
CONCLUSION: 484 
Overall, our results demonstrate the importance of being able to accurately determine a 485 
simultaneous WSR-FMD measurement, provide a reference for the ‘normal’ WSR-FMD 486 
response, and present a number of novel variables that may enable better understanding of 487 
vascular physiology and pathology. 488 
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FIGURE LEGENDS: 591 
Figure 1. Examples of multi-gate spectral Doppler profiles obtained from the ULA-OP 592 
system, in red-to-white color scale, and the related mean frequency, which is overlaid in 593 
blue. The first row shows multi-gate spectral Doppler profiles at baseline at different time 594 
points in the cardiac cycle from the same individual (1A, early systole; 1B, peak systole; 1C, 595 
early diastole). The second row shows multi-gate spectral Doppler profiles during peak 596 
hyperemia at the same time points in the cardiac cycle as Fig 1A-C from the same 597 
participant (1D, early systole; 1E, peak systole; 1F, early diastole). The third row shows 598 
multi-gate spectral Doppler profiles during peak hyperemia at the same time points as Fig 599 
1D-F in the cardiac cycle but from a different participant (1G, early systole; 1H, peak systole; 600 
1J, early diastole). Note the asymmetry in velocity in some profiles (e.g. 1E, 1H and 1J), blunt 601 
profile (1F) and M-shaped profile (1G). Also note the differences in spectral profile during 602 
cardiac cycle as well as between participants. Sub 1, subject 1; Sub 2, subject 2. 603 
 604 
Figure 2. A schematic description of WSR parameters obtained from brachial artery FMD 605 
assessment using continuous multi-gate Doppler and simultaneous diameter. In the upper 606 
panel, traces in light blue and red represent the peak and mean values of WSR, respectively. 607 
In the lower panel, traces in light blue and red represent the variations in diameter (due to 608 
cardiac cycle) and mean diameter of the brachial artery, respectively. WSR, wall shear rate; 609 
SL1, first slope of wall shear rate increase; SL2, second slope of wall shear rate increase; 610 
aucttp, area under the curve until time to peak dilation (area shaded with turquoise); auc, 611 
area under the curve until its return to baseline level (area shaded both with turquoise and 612 
grey); Tp, time to peak value; Tb, time to return to baseline value; Δ, changes. 613 
 614 
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Figure 3. Representative examples of monophasic (upper panel) and biphasic (lower panel) 615 
patterns of WSR increase and diameter changes during brachial artery FMD assessment. 616 
Traces in red represent a mean value of WSR or brachial artery diameter. 617 
 618 
Figure 4. WSR at peak hyperemia (A), WSR auc (B) and absolute WSR increase from baseline 619 
(C) between monophasic (n=15) and biphasic (n=18) WSR increase patterns. Data are shown 620 
as means±SE. *Significantly different from the monophasic group (p<0.05).   621 
 622 
Figure 5. Absolute diameter changes (A) and percentage diameter changes (B) between 623 
monophasic (n=15) and biphasic (n=18) WSR increase patterns. Data are shown as 624 
means±SE. *Significantly different from the monophasic group (p<0.05).   625 
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 Table 1. Selected characteristics of the study participants 626 
 627 
 Values 
Participants, n 33 
Age, yrs 27.5±4.9 
Sex, m/f 14/19 
BMI, kg/m2 22.7±3.1 
Systolic BP, mmHg 114.1±10.4 
Diastolic BP, mmHg 69.2±6.6 
Heart Rate, bpm 64.2±9.5 
 628 
Data are means±SD or numbers. BMI, body mass index; BP, blood pressure.  629 
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Table 2. Parameters of wall shear rate and diameter during brachial artery flow-mediated 630 
dilation and nitroglycerin-mediated dilation assessments in a healthy young cohort 631 
    632 
  Values Ranges 
Flow-mediated dilation (n=33) 
WSR magnitude parameters   
WSR baseline, 1/s 103.9±54.9 17.5 - 222.6 
WSR low-flow, 1/s 32.6±23.4 -1.8 - 94.9 
WSR peak, 1/s 594.9±158.2 269.1 - 924.6 
WSR Δ, 1/s 491.0±160.7 188.4 - 845.0 
WSR %Δ, % 564 (267-994) 155.2 - 3270.5 
WSR aucttp, au 13414±5629 3515 - 30540 
WSR auc, au 17337±6724 4064 - 39473 
WSR time-course parameters   
WSR SL1, 1/s2 79.9±27.3 24.3 - 126.3 
WSR SL2, 1/s2* 16.4±8.8 0.33 - 35.4 
WSR Tp, s 12.2±2.6 7.3 - 20.6 
WSR Tb, s 104.1±36.6 57.5 - 182.5 
Diameter magnitude parameters   
Diameter baseline, mm 3.29±0.45 2.57 - 4.24 
    Diameter Δ, mm 0.21±0.10 0.03 - 0.47 
Diameter %Δ, % 6.5±3.5 0.95 - 14.8 
Diameter time-course parameters   
Diameter Tp, s 55.3±31.2 26.8 - 197.9 
Diameter Tb, s 113.6±59.8 10.5 - 249.5 
Nitroglycerin-mediated dilation (n=13) 
WSR magnitude parameters   
WSR baseline, 1/s 58.6±20.9 33.1 - 101.2 
WSR peak dilation, 1/s 44.7±24.6 17.9 - 87.8 
Diameter magnitude parameters   
Baseline diameter, mm 3.51±0.56 2.48 - 4.30 
Diameter Δ, mm 0.77±0.15 0.56 - 1.10 
Diameter %Δ, % 22.5±4.8 13.8 - 28.4 
  633 
Data are means±SD for variables with normal distribution, median (interquartile range) for 634 
variables with skewed distribution, and range of each variable (minimum to maximum). 635 
*Obtained from 18 participants who showed the biphasic WSR increase response. WSR, wall 636 
shear rate; SL1, first slope of wall shear rate increase; SL2, second slope of wall shear rate 637 
increase; aucttp, area under the curve until time to peak dilation; auc, area under the curve 638 
until its return to baseline value; Tp, time to peak value; Tb, time to return to baseline value; 639 
Δ, changes.  640 
29 
 
                                                                                                                                                                          
Table 3. Partial correlation analysis between parameters of WSR and diameter changes in 641 
the whole cohort. 642 
 643 
 Diameter Δ Diameter % Δ 
WSR baseline r=0.18, p=0.327 r=0.13, p=0.470 
WSR low-flow r=0.32, p=0.072 r=0.32, p=0.077 
WSR SL1 r=0.35, p=0.053 r=0.36, p=0.041 
WSR SL2* r=0.17, p=0.524 r=0.24, p=0.353 
WSR peak r=0.41, p=0.020 r=0.47, p=0.007 
WSR Δ r=0.41, p=0.021 r=0.49. p=0.004 
WSR %Δ r=0.04, p=0.843 r=0.11, p=0.558 
WSR aucttp r=0.34, p=0.061 r=0.42, p=0.017 
WSR auc r=0.46, p=0.008 r=0.56, p=0.001 
WSR Tp r=0.32, p=0.072 r=0.32, p=0.079 
WSR Tb r=0.04, p=0.109 r=0.35, p=0.052 
 644 
*Obtained from 18 participants who showed the biphasic WSR increase response. WSR, wall 645 
shear rate; SL1, first slope of wall shear rate increase; SL2, second slope of wall shear rate 646 
increase; aucttp, area under the curve until time to peak dilation; auc, area under the curve 647 
until its return to baseline value; Tp, time to peak value; Tb, time to return to baseline value; 648 
Δ, changes.   649 
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Table 4. Parameters of wall shear rate and diameter during brachial artery flow-mediated 650 
dilation and nitroglycerin-mediated dilation assessments stratified by monophasic and 651 
biphasic patterns of wall shear rate increase. 652 
 653 
 Monophasic (n=15) Biphasic (n=18) 
Flow-mediated dilation 
WSR magnitude parameters   
WSR baseline, 1/s 89.6±54.6 115.9±53.8* 
WSR low-flow, 1/s 32.7±23.8 32.5±23.7 
WSR %Δ, % 596(181-1374) 552(286-735) 
WSR aucttp, au 10784±4961 15607±5309* 
WSR time-course parameters   
WSR SL1, 1/s2 68.8±30.0 89.1±21.5* 
WSR SL2, 1/s2 - 16.4±8.8 
WSR Tp, s 11.1±3.2 13.2±1.6* 
WSR Tb, s 92.1±31.9 114.1±38.1 
Diameter magnitude parameters   
Diameter baseline, mm 3.29±0.44 3.28±0.47 
Diameter time-course parameters   
Diameter Tp, s 56.6±43.8 54.2±15.8 
Diameter Tb, s 110.8±62.3 116.0±59.3 
Nitroglycerin-mediated dilation (5 monophasic and 8 biphasic) 
WSR magnitude parameters   
WSR baseline, 1/s 43.0±10.2 68.4±20.1* 
WSR peak dilation, 1/s 38.9±21.5 48.3±27.0 
Diameter magnitude parameters   
Baseline diameter, mm 3.38±0.60 3.59±0.56 
Diameter Δ, mm 0.83±0.10 0.74±0.17 
Diameter %Δ, % 25.0±3.9 21.0±4.8 
 654 
Data are means±SD for variables with normal distribution, and median (interquartile range) 655 
for variables with skewed distribution. *significantly different from the monophasic group 656 
(p<0.05). WSR, wall shear rate; SL1, first slope of wall shear rate increase; SL2, second slope 657 
of wall shear rate increase; aucttp, area under the curve until time to peak dilation; auc, 658 
area under the curve until its return to baseline value; Tp, time to peak value; Tb, time to 659 
return to baseline value; Δ, changes. 660 
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